In this presentation, Dr. Jonathan Davis, Director of San Francisco Health Network, Heart Failure Program, provides a brief overview of cardiac considerations. Dr. Davis discusses the cardiac fallouts related to… […]
Keyword: Methamphetamine Use Disorder
Methamphetamine Use Disorder | May 4th 2023
In this presentation, Dr. Jessica Gregg discusses methamphetamine use disorder including a review of the scope of the problem, describes two evidence-based behavioral interventions that can be implemented in the… […]
Pharmacist Toolkit: Methamphetamine Use Disorder (AAPP)
Amphetamines and other stimulants are the second most widely used class of (illicit) drugs globally, after cannabis. This guide by the American Association of Psychiatric Pharmacists is intended to highlight… […]
Read More… from Pharmacist Toolkit: Methamphetamine Use Disorder (AAPP)
Methamphetamine Use Disorder | July 16, 2020
In this presentation, Dr. Jessica Gregg and Dr. Ximena Levander from Oregon Health & Science University discuss the history, chemical structure and epidemiology of methamphetamine use disorder. They also discuss… […]
Read More… from Methamphetamine Use Disorder | July 16, 2020
HCV and People Who Inject Drugs | May 27, 2020
Dr. Jessica Gregg, Associate Professor of Medicine at OHSU, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder. […]
Read More… from HCV and People Who Inject Drugs | May 27, 2020
Methamphetamine Use Disorder | September 5, 2019
Dr. Ximena Levander and Dr. Jessica Gregg, from Oregon Health & Science University, discuss the scope of the methamphetamine epidemic, behavioral interventions, and present research on medications to treat methamphetamine… […]
Read More… from Methamphetamine Use Disorder | September 5, 2019